785 articles
Metashape Pharma's MS 001 paired with semaglutide shows fat-selective weight loss and muscle preservation in preclinical mouse studies.
Chaska Walton is building programmable immune cells that detect and treat multiple Alzheimer's pathologies simultaneously — a potential paradigm shift.
A new imaging breakthrough reveals how immune cells target cancer with nanoscale precision, opening doors for better immunotherapy.
New MIT research shows children develop significantly more DNA damage and cancer from NDMA exposure than adults, due to faster cell division.
A small prospective trial shows adding immunotherapy to chemo before surgery dramatically improves outcomes in complex NSCLC patients.
A 2024 CDC survey reveals 30% of adults sleep under 7 hours nightly, with women hit hardest and millions turning to sleep aids.
A software flaw in True Metrix glucose meters causes dangerous misreadings. FDA urges diabetics to switch devices immediately.
Next-gen CAR-T approaches skip the lab and engineer immune cells directly inside the body, potentially making cancer therapy faster and cheaper.
New actigraphy-based research finds nap duration and frequency predict mortality risk, with morning naps carrying the highest danger signal.
Annovis's buntanetap reduced tau and neuroinflammation markers while improving cognition in mild Alzheimer's patients across a 12-week trial.
Aspen's personalized iPSC cell therapy shows meaningful motor and quality-of-life gains in first 8 Parkinson's patients at 12 months.
Munich's dehaze uses AI to scan the 97% of patient data doctors never see, targeting earlier chronic disease detection at scale.
